A Study on the Immune Response and Safety of the Shingles Vaccine and the Influenza Vaccine When Either is Given to Healthy Adults at the Same Time or Following a COVID-19 Booster Vaccine

NCT05047770 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2013

Enrollment

INDUSTRY

Sponsor class

Conditions

Herpes Zoster

Interventions

BIOLOGICAL: HZ/su
COMBINATION_PRODUCT: Flu D-QIV
BIOLOGICAL: mRNA-1273

Sponsor

GlaxoSmithKline